Fintel reports that on July 20, 2023, Stephens & Co. reiterated coverage of Elevance Health (NYSE:ELV) with a Overweight recommendation.
Analyst Price Forecast Suggests 22.37% Upside
As of July 6, 2023, the average one-year price target for Elevance Health is 582.16. The forecasts range from a low of 517.12 to a high of $651.00. The average price target represents an increase of 22.37% from its latest reported closing price of 475.76.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Elevance Health is 165,476MM, a decrease of 0.14%. The projected annual non-GAAP EPS is 33.02.
What is the Fund Sentiment?
There are 2734 funds or institutions reporting positions in Elevance Health. This is a decrease of 38 owner(s) or 1.37% in the last quarter. Average portfolio weight of all funds dedicated to ELV is 0.58%, a decrease of 2.80%. Total shares owned by institutions increased in the last three months by 33.01% to 321,380K shares. 
The put/call ratio of ELV is 0.66, indicating a bullish outlook.
What are Other Shareholders Doing?
Bank Julius Baer & Co. Ltd, Zurich holds 83,476K shares representing 35.21% ownership of the company. In it's prior filing, the firm reported owning 86K shares, representing an increase of 99.90%. The firm decreased its portfolio allocation in ELV by 10.82% over the last quarter.
Price T Rowe Associates holds 13,277K shares representing 5.60% ownership of the company. In it's prior filing, the firm reported owning 12,726K shares, representing an increase of 4.15%. The firm decreased its portfolio allocation in ELV by 12.97% over the last quarter.
Wellington Management Group Llp holds 8,457K shares representing 3.57% ownership of the company. In it's prior filing, the firm reported owning 8,782K shares, representing a decrease of 3.84%. The firm decreased its portfolio allocation in ELV by 14.69% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 7,353K shares representing 3.10% ownership of the company. In it's prior filing, the firm reported owning 7,259K shares, representing an increase of 1.27%. The firm decreased its portfolio allocation in ELV by 16.16% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 5,573K shares representing 2.35% ownership of the company. In it's prior filing, the firm reported owning 5,521K shares, representing an increase of 0.93%. The firm decreased its portfolio allocation in ELV by 16.09% over the last quarter.
Elevance Health Background Information
(This description is provided by the company.)
Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.
Additional reading:
- Elevance Health Board of Directors Compensation Program, as amended and restated effective May 10, 2023.
- P R E S S R E L E A S E ELEVANCE HEALTH REPORTS SECOND QUARTER 2023 RESULTS
- Form of Incentive Compensation Plan Non Qualified Stock Option Award Agreement for 2023.
- Form of Incentive Compensation Plan Restricted Stock Unit Award Agreement for 2023.
- Form of Incentive Compensation Plan Performance Stock Unit Award Agreement for 2023.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
